GAMCO Asset Management »

Mersana Therapeutics shares owned by GAMCO Asset Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by GAMCO Asset Management from 13F filings

Historical chart of GAMCO Asset Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by GAMCO Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by GAMCO Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $289k 10k 28.93

More positions owned by GAMCO Asset Management

Mueller Industries Equity (MLI)
Gatx Corp Equity (GATX)
Crane Equity (CR)
Madison Square Garden Sports Equity (MSGS)
Herc Holdings Equity (HRI)
American Express Equity (AXP)
Bank Of New York Mellon Corp Equity (BK)
Sony Group Corp - Sp Depository Recei (SONY)
Ametek Equity (AME)
Textron Equity (TXT)
Watts Water Technologies-a Equity (WTS)
National Fuel Gas Equity (NFG)
Modine Manufacturing Equity (MOD)
Republic Services Equity (RSG)
Atlanta Braves Hlds A In-a Equity (BATRA)

View all positions for GAMCO Asset Management

Top funds holding Mersana Therapeutics

Nextech Invest
Bain Capital Life Sciences Investors
Vanguard Group
Rock Springs Capital Management
Knott David M Jr
Acadian Asset Management
Affinity Asset Advisors
Millennium Management
BlackRock
Groupe la Francaise
Rangeley Capital
Gabelli Funds
AQR Capital Management
Geode Capital Management
Credit Industriel Et Commercial

View all funds holding Mersana Therapeutics